166 related articles for article (PubMed ID: 29162097)
21. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor.
Yuanming L; Feng G; Lei T; Ying W
Arch Med Res; 2007 Jan; 38(1):106-12. PubMed ID: 17174733
[TBL] [Abstract][Full Text] [Related]
22. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.
Van der Auwera I; Van den Eynden GG; Colpaert CG; Van Laere SJ; van Dam P; Van Marck EA; Dirix LY; Vermeulen PB
Clin Cancer Res; 2005 Nov; 11(21):7637-42. PubMed ID: 16278382
[TBL] [Abstract][Full Text] [Related]
23. [Expression of lymphatic vessel endothelial hyaluronan receptor-1 in human colorectal cancer and its clinical significance].
Li ZX; Zhang GF; Hu ZQ; Fan YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):511-4. PubMed ID: 19742347
[TBL] [Abstract][Full Text] [Related]
24. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
[TBL] [Abstract][Full Text] [Related]
25. Molecular and cellular mechanisms of lymphangiogenesis.
Al-Rawi MA; Mansel RE; Jiang WG
Eur J Surg Oncol; 2005 Mar; 31(2):117-21. PubMed ID: 15698725
[TBL] [Abstract][Full Text] [Related]
26. High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend?
Rudno-Rudzinska J; Kielan W; Grzebieniak Z; Dziegiel P; Donizy P; Mazur G; Knakiewicz M; Frejlich E; Halon A
Gastric Cancer; 2013 Oct; 16(4):513-20. PubMed ID: 23238856
[TBL] [Abstract][Full Text] [Related]
27. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1.
Kilic N; Oliveira-Ferrer L; Neshat-Vahid S; Irmak S; Obst-Pernberg K; Wurmbach JH; Loges S; Kilic E; Weil J; Lauke H; Tilki D; Singer BB; Ergün S
Blood; 2007 Dec; 110(13):4223-33. PubMed ID: 17761831
[TBL] [Abstract][Full Text] [Related]
28. The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma.
Han FH; Li HM; Zheng DH; He YL; Zhan WH
Eur J Surg Oncol; 2010 Dec; 36(12):1172-9. PubMed ID: 20888167
[TBL] [Abstract][Full Text] [Related]
29. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
[TBL] [Abstract][Full Text] [Related]
30. Endothelial VEGFR-3 expression in colorectal carcinomas is associated with hematogenous metastasis.
Jayasinghe C; Simiantonaki N; Michel-Schmidt R; Kirkpatrick CJ
Oncol Rep; 2009 Nov; 22(5):1093-100. PubMed ID: 19787226
[TBL] [Abstract][Full Text] [Related]
31. Multiple expressions of lymphatic markers and morphological evolution of newly formed lymphatics in lymphangioma and lymph node lymphangiogenesis.
Ji RC; Eshita Y; Xing L; Miura M
Microvasc Res; 2010 Sep; 80(2):195-201. PubMed ID: 20382171
[TBL] [Abstract][Full Text] [Related]
32. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.
Loges S; Clausen H; Reichelt U; Bubenheim M; Erbersdobler A; Schurr P; Yekebas E; Schuch G; Izbicki J; Pantel K; Bokemeyer C; Fiedler W
Clin Cancer Res; 2007 Jan; 13(1):76-80. PubMed ID: 17200341
[TBL] [Abstract][Full Text] [Related]
33. Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis.
Karkkainen MJ; Alitalo K
Semin Cell Dev Biol; 2002 Feb; 13(1):9-18. PubMed ID: 11969367
[TBL] [Abstract][Full Text] [Related]
34. The role of podoplanin in tumor progression and metastasis.
Raica M; Cimpean AM; Ribatti D
Anticancer Res; 2008; 28(5B):2997-3006. PubMed ID: 19031946
[TBL] [Abstract][Full Text] [Related]
35. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers.
Kato S; Shimoda H; Ji RC; Miura M
Anat Sci Int; 2006 Jun; 81(2):71-83. PubMed ID: 16800291
[TBL] [Abstract][Full Text] [Related]
36. [Characterization of markers and growth factors for lymphatic endothelium].
Waś H
Postepy Biochem; 2005; 51(2):209-14. PubMed ID: 16209358
[TBL] [Abstract][Full Text] [Related]
37. Absence of Nkx2-3 homeodomain transcription factor induces the formation of LYVE-1-positive endothelial cysts without lymphatic commitment in the spleen.
Kellermayer Z; Lábadi A; Czömpöly T; Arnold HH; Balogh P
J Histochem Cytochem; 2011 Jul; 59(7):690-700. PubMed ID: 21705651
[TBL] [Abstract][Full Text] [Related]
38. [Clinical and prognostic significance of podoplanin-positive lymphatic vessel density in non-small cell lung carcinoma].
Wang Y; Sun JG; Ye MF; Chen ZT
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):758-61. PubMed ID: 17327058
[TBL] [Abstract][Full Text] [Related]
39. Lymphangiogenesis and breast cancer metastasis.
Cunnick GH; Jiang WG; Gomez KF; Mansel RE
Histol Histopathol; 2002; 17(3):863-70. PubMed ID: 12168797
[TBL] [Abstract][Full Text] [Related]
40. Lymphangiogenesis in tumors: what do we know?
Reis-Filho JS; Schmitt FC
Microsc Res Tech; 2003 Feb; 60(2):171-80. PubMed ID: 12539171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]